IMHA in Canine (Large Breeds)

Gain critical insights into Immune-Mediated Haemolytic Anaemia (IMHA) in Large-Breed Dogs in this specialised presentation by Prof. Dr. Mike Chan, designed for veterinarians, internal medicine specialists, and committed dog owners. IMHA is a life-threatening autoimmune disease where the immune system destroys red blood cells, leading to anaemia, jaundice, and potential organ damage. Causes range from idiopathic immune dysfunction to secondary triggers such as cancer, infections, or drug reactions. Signs include pale gums, lethargy, rapid breathing, dark urine, and weight loss. Diagnosis involves bloodwork, reticulocyte counts, biochemical panels, and vector screening. Management requires urgent intervention—combining hospital-based supportive care, immunosuppressive therapy, and long-term monitoring—with advanced regenerative approaches such as PSC (Precursor Stem Cell Therapy), FOP (Frozen Organo Peptides), FOC (Frozen Organo Cryogenics), plus innovative TopPetPro solutions like MITO Peptide Organotherapy, NANO Peptide Organotherapy, and more—to regulate immunity, support red cell regeneration, and improve survival outcomes.